Predicited 3D-SAR coverage: a prognostic indicator for treament outcome in superficial hyperthermia for breast cancer recurrences at the chest wall?

Predicited 3D-SAR coverage: a prognostic indicator for treament outcome in superficial hyperthermia for breast cancer recurrences at the chest wall? - Predicted 3D-SAR coverage

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34847

Enrollment

Registered

2007-10-19

Start date

2007-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macroscopic breast cancer recurrence 3D-SAR distribution temperature- and energydistributions in breast cancer recurrence

Interventions

energy- and temperature distributions

SAR dosimetry

superficial hyperthermia

thermal dose

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: recurrent tumour of the chest wall, inoperable measurable tumour tumour localisation on the chest wall maximum extension in depth of the tumour not morer than 4cm to obtain the design CT-simulation scan in hyperthermia position without contrast fluid informed consent

Exclusion criteria

Exclusion criteria: no possibility to place 3-4 interstitial thermometry catheters inability to place the required number of Lucite Cone applicators recurrence breast cancer not in previously irradiated area not possible to make an CT-scan (claustrofobic)

Design outcomes

Primary

Measure	Time frame
Measured temperatures Predicted SAR distributions Predicted temperature distribution (both with generic and specific heat sink)	—

Secondary

Measure	Time frame
Complete response rate. Local control. Duration of control. Toxicity.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)